Pfizer Inc(PFE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low26.52
Day High27.04
Open:26.59
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sight Sciences (SGHT)
Pfizer and BioNTech Lock In Next-Gen Pediatric COVID Booster Edge
Pfizer Completes Key Early Study on PF-07328948, Sharpening Its Long-Term Pipeline Story
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), COMPASS Pathways (CMPS) and Pfizer (PFE)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Exagen (XGN) and Warby Parker (WRBY)
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Lipocine (LPCN) and High Tide (HITI)
Wall Street Analysts Are Bullish on Top Healthcare Picks
RBC Capital Remains a Hold on Pfizer (PFE)
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE) and Allogene Therapeutics (ALLO)
Analysts Are Bullish on Top Healthcare Stocks: BioNTech SE (BNTX), Pfizer (PFE)
Pfizer Inc Earnings Call Signals Cautious Optimism
J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

Profile

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.'The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.